Back
Immuron Vs. Alterity Therapeutics Industry Stock Comparison
Sell
26
IMRN
Immuron
Last Price:
1.83
Seasonality Move:
9.64%
Sell
23
ATHE
Alterity Therapeutics
Last Price:
1.08
Seasonality Move:
-3.88%
Sell
26
Immuron (IMRN)
is a Sell
Is Immuron a Buy, Sell or Hold?
- The current Immuron [IMRN] share price is $1.88. The Score for IMRN is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- IMRN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Alterity Therapeutics (ATHE)
is a Sell
Is Alterity Therapeutics a Buy, Sell or Hold?
- The current Alterity Therapeutics [ATHE] share price is $1.07. The Score for ATHE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ATHE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IMRN Stock Price Chart
ATHE Stock Price Chart
What is Alterity Therapeutics's stock price today?
-
The Alterity Therapeutics share price today is $1.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATHE is experiencing slight buying pressure.
IMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 43.48 | Sell |
| Chaikin Money Flow: | 2063 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.85 - 1.97) | Sell |
| Bollinger Bands (100): | (2.03 - 2.67) | Sell |
ATHE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 37.67 | Sell |
| Chaikin Money Flow: | 12472 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.11 - 1.19) | Sell |
| Bollinger Bands (100): | (1.12 - 1.62) | Sell |
IMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.88 | Buy |
| 20-day SMA: | 1.9 | Sell |
| 50-day SMA: | 2.2 | Sell |
| 200-day SMA: | 2.36 | Sell |
| 8-day EMA: | 1.88 | Buy |
| 20-day EMA: | 1.92 | Sell |
| 50-day EMA: | 2.11 | Sell |
| 200-day EMA: | 2.27 | Sell |
ATHE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.11 | Sell |
| 20-day SMA: | 1.14 | Sell |
| 50-day SMA: | 1.22 | Sell |
| 200-day SMA: | 1.66 | Sell |
| 8-day EMA: | 1.1 | Sell |
| 20-day EMA: | 1.14 | Sell |
| 50-day EMA: | 1.22 | Sell |
| 200-day EMA: | 1.65 | Sell |
Immuron Earnings Growth & IMRN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alterity Therapeutics Earnings Growth & ATHE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.00 per share.
Immuron Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alterity Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||